Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Caixin Futures Agricultural Products Strategy: Palm Oil Remains Strong Amid Fluctuations, Short Selling Recommended for Live Hogs and Eggs at Highs

Caixin Futures Agricultural Products Strategy: Palm Oil Remains Strong Amid Fluctuations, Short Selling Recommended for Live Hogs and Eggs at Highs

汇通财经汇通财经2026/03/19 13:09
Show original
⑴ Palm Oil: The overnight rebound in international oil prices provided some support, but domestic oil futures, after surging in the early session, failed to maintain momentum as funds remained cautious. In the spot market, Guangdong 24-degree palm oil spot price rose by 30 yuan to 9,720 yuan. Pay attention to the support at the 10-day moving average; the trend is expected to remain strong with fluctuations. ⑵ Soybean Meal: The surge in crude oil prices has driven up vegetable oil prices, pushing up the cost of imported soybeans. Domestic soybean imports from January to March saw a significant decline, and customs clearance delays have further tightened short-term supply, pushing up meal prices. However, after April, the volume of imported soybeans will gradually recover. Beware of the risk of price corrections in the market; it is recommended to remain on the sidelines for now. ⑶ Corn: The main reason for the strong price is that inventories at northern ports remain lower year-on-year, but the release of policy grain and the supply of wheat and rice are limiting the upside. Feed demand is not strong due to weak prices of livestock products, while demand for deep processing remains robust. Prices are expected to fluctuate at high levels in the short term, with limited upside; it is recommended to remain on the sidelines for now. ⑷ Live Hogs: Significant supply pressure is the core reason for the continued price decline. The absolute number of breeding sows remains above the normal retention level, and medium-term supply remains high. It is recommended to maintain a strategy of selling on rallies for the 05 contract. ⑸ Eggs: Rising feed costs and marginally reduced supply pressure are jointly driving the market. The feed cost per jin of eggs has risen to about 3.13 yuan. Although the number of laying hens in production remains high, the worst period may have passed. Prices are expected to rise moderately, but high inventory levels will limit the upside; it is recommended to sell on rallies.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53